Wells Fargo’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $688K | Sell |
|
|||||
|
2025
Q1 | $565K | Buy |
|
|||||
|
2024
Q4 | $634K | Sell |
|
|||||
|
2024
Q3 | $3.97M | Buy |
|
|||||
|
2024
Q2 | $351K | Buy |
|
|||||
|
2024
Q1 | $328K | Buy |
|
|||||
|
2023
Q4 | $99K | Buy |
|
|||||
|
2023
Q3 | $53.8K | Sell |
|
|||||
|
2023
Q2 | $178K | Buy |
|
|||||
|
2023
Q1 | $93.7K | Buy |
|
|||||
|
2022
Q4 | $5.48K | Sell |
|
|||||
|
2022
Q3 | $27K | Sell |
|
|||||
|
2022
Q2 | $29K | Sell |
|
|||||
|
2022
Q1 | $80K | Sell |
|
|||||
|
2021
Q4 | $292K | Sell |
|
|||||
|
2021
Q3 | $565K | Sell |
|
|||||
|
2021
Q2 | $1.02M | Sell |
|
|||||
|
2021
Q1 | $8.79M | Buy |
|
|||||
|
2020
Q4 | $6.26M | Buy |
|
|||||
|
2020
Q3 | $1.27M | Buy |
|
|||||
|
2020
Q2 | $568K | Buy |
|
|||||
|
2020
Q1 | $262K | Sell |
|
|||||
|
2019
Q4 | $216K | Sell |
|
|||||
|
2019
Q3 | $168K | Buy |
|
|||||
|
2019
Q2 | $136K | Sell |
|
|||||
|
2019
Q1 | $134K | Sell |
|
|||||
|
2018
Q4 | $134K | Sell |
|
|||||
|
2018
Q3 | $310K | Buy |
|
|||||
|
2018
Q2 | $222K | Sell |
|
|||||
|
2018
Q1 | $218K | Sell |
|
|||||
|
2017
Q4 | $296K | Sell |
|
|||||
|
2017
Q3 | $463K | Sell |
|
|||||
|
2017
Q2 | $701K | Sell |
|
|||||
|
2017
Q1 | $807K | Buy |
|
|||||
|
2016
Q4 | $582K | Buy |
|
|||||
|
2016
Q3 | $266K | Buy |
|
|||||
|
2016
Q2 | $188K | Sell |
|
|||||
|
2016
Q1 | $429K | Buy |
|
|||||
|
2015
Q4 | $206K | Buy |
|
|||||
|
2015
Q3 | $302K | Buy |
|
|||||
|
2015
Q2 | $340K | Buy |
|
|||||
|
2015
Q1 | $247K | Buy |
|
|||||
|
2014
Q4 | $6K | Buy |
|